Dr. Monica M. Bertagnolli: Renewed Focus on Caring for and Learning From Patients
Monica M. Bertagnolli, MD, FACS, FASCO, has always been a trailblazer, both in her field and in the ranks of leadership. Her next role? 2018–2019 ASCO President.
FEATURED BLOGS
Jul 11, 2018
Every patient with cancer deserves equal access to the highest quality care and the opportunity to participate in research.
Jul 11, 2018
ASCO CMO Dr. Richard L. Schilsky invites all cancer researchers to come together for education and networking around cancer clinical trials.
Jul 11, 2018
Thanks to Conquer Cancer grants, when Dr. Dorothy C. Lombe treats patients with cervical cancer in Zambia, "I will be able to hold more women’s hands and say yes where I had previously said no."
Jul 09, 2018
I am really pleased to have with us ASCO's Chief Medical Officer and Senior Vice President for a conversation focusing on right-to-try policies.
Jun 22, 2018
At the most recent meeting, ASCO's delegation to the AMA House of Delegates were involved in resolutions related to Pharmacy Benefit Managers, opioids, billing for survivorship care plans, alcohol as...
Jun 19, 2018
This was a patient who needed to do cancer her way, and making it about me was not going to work.
Jun 11, 2018
As a pragmatic investigator and physician who has witnessed remarkable progress in the treatments we can now offer individuals with cancer, I believe the FDA’s support of more rapid and nimble...
Advertisement
2018 ASCO Annual Meeting: Delivering Discoveries, Expanding the Reach of Precision Medicine
Latest Comments & Discussions
Jul 07, 2018
Thank you for your interest in ASCO's Leadership Development Program. The application is open until September 25. Program details and...
Raju Kumar Vaddepally, MBBS, MD
Jul 06, 2018
I am interested in asco leadership development program, how can enroll in to this opportunity? I am early career oncologist.
...
ASCO University
Jun 27, 2018
Thank you to Drs. Dunlap and Porter for leading the discussion of this case and also to all of those who contributed to the conversation!...
Jennifer Dunlap
Jun 27, 2018
Course Faculty Summary
CAR-T cell therapy is a type of immunotherapy in which patient’s T cells are engineered to express a chimeric...
David Porter
Jun 27, 2018
Course Faculty Summary
For patients with relapsed or refractory ALL, allogeneic SCT offers a low chance of cure while treatment with...
Pages
Most Read
Dr. Arjun Gupta reconsidered an order (and the evidence) for a neutropenic diet when it negatively affected his patient's quality of life.
This was a patient who needed to do cancer her way, and making it about me was not going to work.
Monica M. Bertagnolli, MD, FACS, FASCO, has always been a trailblazer, both in her field and in the ranks of leadership. Her next role? 2018–2019 ASCO President.
At the most recent Board of Directors meeting, we heard insightful presentations from participants in the Leadership Development Program, pivoted toward the execution of our 5-year strategic plan, and had a valuable conversation with NCI director Dr. Norman Sharpless.
As a pragmatic investigator and physician who has witnessed remarkable progress in the treatments we can now offer individuals with cancer, I believe the FDA’s support of more rapid and nimble testing and approval of new therapies should be applauded.
Michal Tibbits